FDA Inspection
Vivus, LLC.Vivus, LLC. – FDA Inspection, Sep 28, 2026
Record Details
This FDA Inspection record concerns Vivus, LLC., with an inspection on September 28, 2026, issued by the San Francisco District Office, covering human drugs.
View Company Profile
ID · 26cb5c82-6f36-457e-9b98-5f9d226b776f
Inspection Facts
- Inspection number
- 1338264
- FDA center
- Human Drugs
- Project area
- Postmarket Surv. and Epidemiology
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vivus, LLC.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 8, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 28, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 31, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 26, 2013 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 30, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Vivus, LLC.
- FDA Inspection 1218963 - 2023-09-08
- FDA Inspection 1081231 - 2018-11-28
- FDA Inspection 865709 - 2014-01-31
- FDA Inspection 829906 - 2013-04-26
- FDA Inspection 756318 - 2011-11-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.